Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 04, 2024

SELL
$233.45 - $247.73 $321,460 - $341,124
-1,377 Reduced 59.53%
936 $232 Million
Q4 2023

Jan 11, 2024

SELL
$232.24 - $267.23 $250,819 - $288,608
-1,080 Reduced 31.83%
2,313 $564 Million
Q1 2022

Apr 12, 2022

SELL
$243.64 - $270.48 $98,430 - $109,273
-404 Reduced 10.64%
3,393 $903,000
Q4 2021

Jan 13, 2022

SELL
$230.08 - $250.94 $25,078 - $27,352
-109 Reduced 2.79%
3,797 $994,000
Q3 2021

Oct 01, 2021

SELL
$232.72 - $256.47 $65,394 - $72,068
-281 Reduced 6.71%
3,906 $960,000
Q2 2021

Jul 08, 2021

SELL
$232.65 - $254.58 $21,636 - $23,675
-93 Reduced 2.17%
4,187 $1.03 Million
Q4 2020

Jan 13, 2021

SELL
$221.92 - $245.94 $31,956 - $35,415
-144 Reduced 3.25%
4,280 $1.07 Million
Q3 2020

Oct 06, 2020

SELL
$215.77 - $276.76 $9,062 - $11,623
-42 Reduced 0.94%
4,424 $1.02 Million
Q2 2020

Jul 06, 2020

SELL
$219.9 - $263.41 $16,492 - $19,755
-75 Reduced 1.65%
4,466 $1.07 Million
Q1 2020

Apr 02, 2020

SELL
$195.69 - $279.01 $14,872 - $21,204
-76 Reduced 1.65%
4,541 $1.04 Million
Q4 2019

Jan 17, 2020

SELL
$236.45 - $266.82 $2,128 - $2,401
-9 Reduced 0.19%
4,617 $1.28 Million
Q3 2019

Oct 01, 2019

SELL
$230.58 - $256.08 $18,215 - $20,230
-79 Reduced 1.68%
4,626 $1.18 Million
Q2 2019

Jul 11, 2019

BUY
$217.4 - $246.08 $73,263 - $82,928
337 Added 7.72%
4,705 $1.19 Million
Q1 2019

Apr 04, 2019

BUY
$206.05 - $248.17 $55,015 - $66,261
267 Added 6.51%
4,368 $1.09 Million
Q4 2018

Jan 25, 2019

BUY
$204.73 - $257.93 $839,597 - $1.06 Million
4,101 New
4,101 $924,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Orrstown Financial Services Inc Portfolio

Follow Orrstown Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orrstown Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Orrstown Financial Services Inc with notifications on news.